Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |